237 Aufrufe 237 0 Kommentare 0 Kommentare

    FDA Authorizes ZYN ULTRA Nicotine Pouches Following Scientific Review

    FDA Authorizes ZYN ULTRA Nicotine Pouches Following Scientific Review

    Philip Morris International Inc. (NYSE: PM) today announces that the U.S. Food and Drug Administration (FDA) issued Marketing Granted Orders to PMI’s U.S. affiliate, Swedish Match USA, Inc., authorizing the marketing of 11 ZYN ULTRA moist oral nicotine pouch products, including all 9mg variants and one 11mg variant. Additional 11mg variants remain under scientific review.

    Today’s action further enhances PMI’s leadership role in the smoke-free category.

    “We are delighted with the FDA’s decision to authorize a range of ZYN ULTRA products, which will build on ZYN’s position as America’s leading smoke-free product brand,” said Stacey Kennedy, PMI U.S. CEO. “We look forward to expanding our portfolio of better choices for the 45 million Americans who consume nicotine products.”

    ZYN ULTRA positions the brand to further extend its category leadership among legal-age consumers of nicotine products. Like the flagship FDA-authorized ZYN pouches, ZYN ULTRA, with its higher moisture content, is free of tobacco-leaf.

    Today’s decisions build on the FDA’s earlier authorizations of ZYN in multiple flavors and both 3mg and 6 mg variants. ZYN was the first nicotine pouch authorized for sale in the United States following rigorous scientific review. PMI leads the industry in securing FDA authorizations, reinforcing its commitment to transparency and science-based regulation.

    These authorizations underscore PMI U.S.’s commitment to innovation and responsible marketing practices to adults aged 21+, as the company works to offer alternatives that are a much better choice than continuing to smoke.

    The FDA authorized the following products in 9 mg nicotine concentrations:

    • ZYN ULTRA Smooth (commercialized as Signature Smooth)
    • ZYN ULTRA Cool Mint (commercialized as Arctic Mint)
    • ZYN ULTRA Spearmint (commercialized as Fresh Spearmint)
    • ZYN ULTRA Wintergreen (commercialized as Wintergreen Blast)
    • ZYN ULTRA Peppermint (commercialized as Peppermint Frost)
    • ZYN ULTRA Citrus (commercialized as Citrus Zest)
    • ZYN ULTRA Chill (commercialized as Chill Mist)
    • ZYN ULTRA Menthol (commercialized as Menthol Ice)
    • ZYN ULTRA Deep Freeze
    • ZYN ULTRA Wintergreen Chill

    The FDA authorized the following product in 11mg nicotine concentration:

    Seite 1 von 4 





    Business Wire (engl.)
    0 Follower
    Autor folgen

    FDA Authorizes ZYN ULTRA Nicotine Pouches Following Scientific Review Philip Morris International Inc. (NYSE: PM) today announces that the U.S. Food and Drug Administration (FDA) issued Marketing Granted Orders to PMI’s U.S. affiliate, Swedish Match USA, Inc., authorizing the marketing of 11 ZYN ULTRA moist oral …

    Im Durchschnitt erleiden 7 von 10 Kleinanlegern Verluste beim Handel mit Turbo-Zertifikaten. Turbo-Zertifikate sind hoch risikoreiche Produkte und nicht für langfristige Anlagestrategien geeignet.
    Profitieren Sie von unserem Alleinstellungsmerkmal als den zentralen verlagsunabhängigen Wissens-Hub für einen aktuellen und fundierten Zugang in die Börsen- und Wirtschaftswelt, um strategische Entscheidungen zu treffen.
    • ✅ Größte Finanz-Community Deutschlands
    • ✅ über 550.000 registrierte Nutzer
    • ✅ rund 2.000 Beiträge pro Tag
    • ✅ verlagsunabhängige Partner ARIVA, FinanzNachrichten und BörsenNews
    • ✅ Jederzeit einfach handeln beim SMARTBROKER+
    • ✅ mehr als 25 Jahre Marktpräsenz
    Aktien von A - Z: # A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
    wallstreetONLINE bei X wallstreetONLINE bei Instagram wallstreetONLINE bei Facebook wallstreetONLINE bei Youtube wallstreetONLINE bei LinkedIn
    Unsere Apps: Apple App Store Icon Google Play Store Icon
    Wenn Sie Kursdaten, Widgets oder andere Finanzinformationen benötigen, hilft Ihnen ARIVA gerne. 

    Unsere User schätzen wallstreet-online.de: 4.8 von 5 Sternen ermittelt aus 285 Bewertungen bei www.kagels-trading.de
    Zeitverzögerung der Kursdaten: Deutsche Börsen +15 Min. NASDAQ +15 Min. NYSE +20 Min. AMEX +20 Min. Dow Jones +15 Min. Alle Angaben ohne Gewähr.
    Copyright © 1998-2026 Smartbroker Holding AG - Alle Rechte vorbehalten.
    Mit Unterstützung von: Ariva Smartbroker+
    Daten & Kurse von: TTMzero